| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5590847 | Multiple Sclerosis and Related Disorders | 2017 | 17 Pages |
Abstract
Our study suggested that immunosuppressors for the prevention of relapse should be administered without delay in patients with NMOSD and PTS. Owing to the side effects of carbamazepine, we recommend oxcarbazepine as the first-line of treatment for PTS in patients with NMOSD. Whether PTS is a marker of disease severity in NMOSD remains to be determined, requiring a long-term prospective observational study.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Ju Liu, Qin Zhang, Zhiyun Lian, Hongxi Chen, Ziyan Shi, Huiru Feng, Xiaohui Miao, Qin Du, Hongyu Zhou,